The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

Vaccine

Volumn 31, Issue 8, 2013, Pages 1246-1254

  Wijnans, Leonoor ^a,b   Lecomte, Coralie ^a   de Vries, Corinne ^c   Weibel, Daniel ^a,d   Sammon, Cormac ^c   Hviid, Anders ^e   Svanström, Henrik ^e   Mølgaard Nielsen, Ditte ^e   Heijbel, Harald ^f   Dahlström, Lisen Arnheim ^g   Hallgren, Jonas ^g   Sparen, Par ^g   Jennum, Poul ^h   Mosseveld, Mees ^a   Schuemie, Martijn ^a   van der Maas, Nicoline ⁱ   Partinen, Markku ^j   Romio, Silvana ^a   Trotta, Francesco ^k   Santuccio, Carmela ^k   Menna, Angelo ^l   Plazzi, Giuseppe ^m   Moghadam, Keivan Kaveh ^m   Ferro, Salvatore ^l   Lammers, Gert Jan ⁿ   Overeem, Sebastiaan ^o   Johansen, Kari ^p   Kramarz, Piotr ^p   Bonhoeffer, Jan ^d,q   Sturkenboom, Miriam C J M ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDICINES EVALUATION BOARD   (Netherlands)

^c UNIVERSITY OF BATH   (United Kingdom)

^d Brighton Collaboration   (Switzerland)

^e STATENS SERUM INSTITUT   (Denmark)

^f SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

^h Danish Center Institute   (Denmark)

ⁱ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^j Helsingin Uniklinikka   (Finland)

^k ITALIAN MEDICINES AGENCY   (Italy)

^l Regional Health Authority   (Italy)

^m UNIVERSITY OF BOLOGNA   (Italy)

ⁿ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^o RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^p EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^q UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

more..

Author keywords

ASO3B adjuvant; Background rates; Incidence; Influenza vaccine; Narcolepsy

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DENMARK; DRUG SAFETY; FALSE POSITIVE RESULT; FINLAND; HEALTH PROGRAM; HUMAN; INCIDENCE; INFLUENZA VACCINATION; ITALY; MAJOR CLINICAL STUDY; NARCOLEPSY; NETHERLANDS; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SWEDEN; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EUROPE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NARCOLEPSY; RETROSPECTIVE STUDIES; VACCINATION; YOUNG ADULT;

EID: 84873082021     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.015     Document Type: Article

References (44)

1. International Classification of Sleep Disorders 2005, American Academy of Sleep Medicine, Westchester, IL. ICSD (Ed.).
2. Overeem S., Black, Lammers G. Narcolepsy: immunological aspects. Sleep Med Rev 2008, 12:95-107.
3. Littner M., Kushida C., Wise M., Davila D., Morgenthaler T., Lee-Chiong T., et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005, 28(1):113-121.
4. Mignot E., Lammers G., Ripley B., Okun M., Nevsimalova S., Overeem S., et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002, 59(10):1553-1562.
5. Guilleminault C., Abad V. Narcolepsy. Sleep disorders medicine basic science, technical considerations, and clinical aspects 2009, 377-396. Elsevier Inc., Philadelphia. 3rd ed. S. Chokroverty (Ed.).
6. Chakravorty S., Rye D. Narcolepsy in the older adult: epidemiology, diagnosis and management. Drugs Aging 2003, 20(5):361-376.
7. Morrish E., King M., Smith I., Shneerson J. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med Rev 2004, 5:37-41.
8. Serra L., Montagna P., Mignot E., Lugaresi E., Plazzi G. Cataplexy features in childhood narcolepsy. Mov Disord 2008, 23:858-865.
9. Plazzi G., Pizza F., Palaia V., Franceschini C., Poli F., Moghadam K. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011, 134:3480-3492.
10. Nevsimalova S. Narcolepsy in childhood. Sleep Med Rev 2009, 13(2):169-180.
11. Ahmed I., Thorpy M. Clinical features, diagnosis and treatment of narcolepsy. Clin Chest Med 2010, 31(2):371-381.
12. Longstreth W.J., Koepsell T., Ton T., Hendrickson A., van Belle G. The epidemiology of narcolepsy. Sleep 2007, 30(1):13-26.
13. Overeem s, Mignot E., van Dijk J., Lammers G. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001, 18:78-105.
14. Dauvilliers Y., Montplaisir J., Molinari N., Carlander B., Ondze B., Besset A., et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001, 57:2029-2033.
15. Chakravorty S.S., Rye D.B. Narcolepsy in the older adult: epidemiology, diagnosis and management. Drugs Aging 2003, 20(5):361-376.
16. Yoss R., Daly D. Narcolepsy in children. Pediatrics 1960, 25:1025-1033.
17. Fronczek R., Baumann C., Lammers G., Bassetti C., Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Med Rev 2009, 13:9-22.
18. Aran A., Lin L., Nevsimalova S., Plazzi G., Hong S., Weiner K., et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009, 32:979-983.
19. Cvetkovic-Lopes V., Bayer L., Dorsaz S., Maret S., Pradervand S., Dauvilliers Y., et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010, 120(3):713-719.
20. Kornum B., Faraco J., Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 2011, 21:897-903.
21. Han F., Lin L., Warby S., Faraco J., Li J., Dong S., et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011, 70(3):410-417.
22. Vaccine European New Integrated Collaboration Effort (VENICE). Pandemic A(H1N1)2009 influenza vaccination survey, influenza season 2009/2010. VENICE-II consortium. 2011. Available at:. http://venice.cineca.org/Final_Report_VENICE_Pandemic_Influenza_2009.pdf.
23. Paul Ehrlich Institute: Aktuelle Informationen zu Narkolepsie im zeitlichen Zusammenhang mit A/H1N1 Impfung. Available at:. http://www.pei.de/cln_320/nn_2299076/DE/arzneimittelsicherheit-vigilanz/archiv-sicherheitsinformationen/2012/ablage2012/2012-09-27-narkolepsie-studien-europa.html%3Futm_medium=twitter%26utm_source=dlvr.it.
24. Folkehelseinstitutt Pandemrix og narkolepsi. Available at:. http://www.fhi.no/eway/default.aspx%3Fpid=233%26trg=MainLeft_5565%26MainArea_5661=5565%3A0%3A15,5001%3A1%3A0%3A0%3A%3A%3A0%3A0%26MainLeft_5565=5544%3A91109%3A%3A1%3A5569%3A8%3A%3A%3A0%3A0.
25. AFSSAPS. Vaccins pandémiques grippe A(H1N1) et narcolepsie - Actualisation des données-Communiqué. Available at:. http://ansm.sante.fr/S-informer/Presse-Communiques-Points-presse/Vaccins-pandemiques-grippe-A-H1N1-et-narcolepsie-Actualisation-des-donnees-Communique/(language)/fre-FR.
26. Dauvilliers Y., Montplaisir J., Cochen V., Desautels A., Einen M., Lin L., et al. Post-H1N1 narcolepsy-cataplexy. Sleep 2010, 33:1428-1430.
27. Nohynek H., Jokinen J., Partinen M., Vaarala O., Kirjavinen T., Sundman J., et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012, 7(3):e33536.
28. National Narcolepsy Task Force. Interim Report, 31 January 2011, National Institute for Health and welfare (THL),. http://www.thl.fi/.
29. Medical Products Agency. A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix - a first and preliminary report; 2011. Available from: [cited March 28,2011]. http://www.mpa.se/.
30. MPA Sweden. Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations - results of a case inventory study by the MPA in Sweden during 2009-2010; June 30, 2011.
31. O'Flanagan D, Bonner C, Crowe C, Lynch B, Sweeney B, Gilvarry J, et al. Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010. Final Report of National Narcolepsy Study Steering Committee. Department of Health, Ireland; 2012.
32. Grippe, Vaccination Antigrippale et Narcolepsie: contribution française à l'étude cas-témoins européenne: RAPPORT FINAL Version 2.0 du 6 août 2012. Source: [last accessed 30-09-12]. http://ansm.sante.fr/S-informer/Actualite/Vaccins-pandemiques-grippe-A-H1N1-et-narcolepsie-Resultats-de-l-etude-europeenne-et-de-l-etude-cas-temoins-francaise-Point-d-information.
33. European Centre for Disease Prevention and Control. Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation) Stockholm: ECDC; September 2012. Available at:. http://www.http%3a//vaesco.net/vaesco/results/main/04/text_files/file/ECDC%202012%20VAESCO%20Narco%20report%20FULL.pdf.
34. Vlug A., van der Lei J., Mosseveld B., van Wijk M., van der Linden P., Sturkenboom M., et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999, 38:339-344.
35. Wood L., Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004, 27(12):871-881.
36. Andersen T., Madsen M., Jorgensen J., Mellemkjoer L., Olsen J. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46:3.
37. Malig C. The Civil Registration System in Denmark. IIVRS Technical Paper. Report. Report No.: 66. Bethesda, Maryland: International Institute for Vital Registration and Statistics; 1996.
38. Avillach P., Mougin F., Joubert M., Thiessard F., Pariente A., Dufour J., et al. A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. Stud Health Technol Inform 2009, 150:190-194.
39. Poli F, Overeem S, Lammers GJ, Plazz, G, Lecendreux M, Keene D, et al. Narcolepsy as a possible adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine 2012,. doi:10.1016/j.vaccine.2012.12.014.
40. Coloma P., Schuemie M., Trifirò G., Gini R., Herings R., Hippisley-Cox J., et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 2011, 20:1-11.
41. Black S., Eskola J., Siegrist C.A., Halsey N., Macdonald N., Law B., et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet 2009 Dec 19, 374(9707):2115-2122.
42. Silber M., Krahn L., Olson E., Pankratz V. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 2002, 25:197-202.
43. Mereckiene J., Cotter S., Weber J., Nicoll A., D'Ancona F., Lopalco P., et al. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill 2012, pii: 20064.
44. Ludvigsson J., Otterblad-Olausson P., Pettersson B., Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009, 24:659-666.